Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

Ashwin Somasundaram, Timothy F Burns Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA Abstract: Lung cancer is the leading killer of both men and women in the US, and the 5-year survival remains poor. However, the approv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Somasundaram A, Burns TF
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/1a44d40d230a4cbfab4a5686cc2ef827
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!